Suchergebnisse - "Usmani, Saad Z"

PubPharm (305)

1

Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone : Patient-reported outcomes from GRIFFIN

enthalten in: American journal of hematology | 2024

von Silbermann, R. | Laubach, J. | Kaufman, J. | +23

2

ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Relapsed Refractory Multiple Myeloma after Failure of Chimeric Antigen Receptor T-Cell Therapy

enthalten in: Transplantation and cellular therapy | 2024

von Hashmi, H. | Kumar, A. | Kharfan-Dabaja, M. | +10

3

Unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies

enthalten in: Blood advances | 2024

von Howard, A. | Concepcion, I. | Wang, A. | +18

4

Patterns of CRS with Teclistamab in Relapsed/Refractory Multiple Myeloma patients with Prior T-Cell Redirection Therapy

enthalten in: Blood advances | 2024

von Hamadeh, I. | Shekarkhand, T. | Rueda, C. | +19

5

CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma

enthalten in: Blood advances | 2024

von Firestone, R. | McAvoy, D. | Shekarkhand, T. | +23

6

Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study

enthalten in: British journal of haematology | 2024

von Nooka, A. | Kaufman, J. | Rodriguez, C. | +16

7

Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data

enthalten in: Advances in therapy | 2024

von Durie, B. | Kumar, S. | Ammann, E. | +5

8

Teclistamab Improves Patient-Reported Symptoms and Health-Related Quality of Life in Relapsed or Refractory Multiple Myeloma : Results From the Phase II MajesTEC-1 Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Martin, T. | Moreau, P. | Usmani, S. | +20

9

Pre-diagnosis dietary patterns and risk of multiple myeloma in the NIH-AARP diet and health study

enthalten in: Leukemia | 2024

von Castro, F. | Parikh, R. | Eustaquio, J. | +5

UpdateOf: medRxiv. 2023 Sep 23;:. - PMID 37790335

10

Dietary risk factors for monoclonal gammopathy of undetermined significance in a racially diverse population

enthalten in: Blood advances | 2024

von Joseph, J. | Hillengass, J. | Tang, L. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]